Supported by Health Professionals Bank. The results of this survey equips APNA members with information on the workforce conditions of your profession, and helps APNA’s develop evidence-based policy and programs relating to the primary health care nurse workforce and to advocate for you.
Meningococcal: Impacting all ages - Associate Professor Michael Nissen
This is a Breakfast Session at APNA's 10th annual conference for nurses working in primary health care: - Meningococcal: Impacting all ages - Associate Professor Michael Nissen.
Invasive Meningococcal Disease (IMD) is a rare but deadly bacterial infection most commonly presenting as sepsis or meningitis. In Australia, cases of IMD have been steadily increasing over the last five years (2013-2017), with 2017 recording the highest number of cases seen since 2006. The most vulnerable population for IMD are infants and young children, particularly those under 12 months, but further peaks of disease occur in adolescents, and are emerging in older adults too.
Vaccination is an important way health care providers can help to protect patients against IMD.
Several meningococcal vaccines exist to help protect against the serogroups common to Australia. However, not all of these vaccines are available on the National Immunisation Program. This session will assist you to build the knowledge in order to help answer questions about the disease and the vaccines available to help protect them against IMD.